Patent details

Basic Information

Publication number:

LUC00019

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP097020747

Legal Status:

Inactive

Application number:

LUC00019

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/14/914

Marketing Authorization Type:

Marketing Authorization Date:

30/04/2014

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Luxembourg (LU)

Dates

Filing date:

22/05/2017

First Marketing Authorization date:

30/04/2014

Grant date:

03/08/2017

Activation date:

Publication date:

26/05/2017

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

30/04/2029

SPC Extension Expiration:

30/04/2029

Rejection date:

Withdrawal date:

Owner

From:

22/05/2017

 

 

Name:

BioMarin Pharmaceutical Inc.

Address:

105 Digital Drive, Novato, CA 94949, United States (US)

Agent

Name:

Office FREYLINGER S.A.

From:

22/05/2017

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Publication

Bulletin

1

Bulletin Heading:

SPC1

Bulletin edition number:

2017/03

Publication date:

21/07/2017

Description:

Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:

SPC2

Bulletin edition number:

2017/05

Publication date:

13/09/2017

Description:

Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:

31/01/2029

Annual Fee Number:

21

Annual Fee Amount:

410 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
26/05/2017	Publication	1
26/05/2017	Outgoing Correspondence	1
22/05/2017	General Document	3
22/05/2017	General Document	25
22/05/2017	General Document	3
14/06/2017	Incoming Correspondence (Post)	2
22/05/2017	Application Form	4